Who Owns Boundless Bio Inc (BOLD)? 13F Institutional Holders (Q2 2026)

BOLD ranks #6672 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

41 institutions disclose a position in BOLD, but none treat it as a major bet — even ARCH Venture Management, LLC, its most concentrated holder, allocates just 0.6% of its own portfolio to it.

Jim Simons has added to its BOLD position for two straight quarters, increasing it by $769.2K to reach $1.2M today.

Ken Griffin has trimmed its BOLD position for two straight quarters, cutting it by $1.3M while still holding $362.6K.

BOLD is down 0% today, but institutions show net buying of $19.5M this quarter — a divergence between today's price move and the underlying institutional flow.

BOLD reported a net loss of $58.2M in its latest fiscal year.

• Not yet profitable — net loss of $58.2M in the latest fiscal year
• Net income improved year over year, from -$65.4M to -$58.2M
• Operating cash flow was negative, using $46.7M in cash
• Current ratio of 8.74x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.59x equity — within a conventional range